RESEARCH PAPER
Causes and predictors of hospitalization
and in-hospital mortality among HIV/AIDS
patients on highly active antiretroviral
therapy in secondary and tertiary care
hospitals in Oromia Regional State:
multi-center cross-sectional study
1
Department of Pharmacy, Clinical Pharmacy Course Unit, Ambo University, Ambo, Ethiopia
2
Department of Clinical Pharmacy, School of Pharmacy, Institute of Health Sciences, Jimma University, Jimma, Ethiopia
3
Department of Nursing, College of Health Sciences, Salale University, Fitche, Ethiopia
Submission date: 2020-08-09
Final revision date: 2020-09-29
Acceptance date: 2020-09-30
Publication date: 2021-06-30
HIV & AIDS Review 2021;20(2):102-108
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Highly active antiretroviral therapies (HAART) decrease the incidence, morbidity, and mortality of acquired immunodeficiency syndrome (AIDS) dramatically. However, current research reported an increased hospitalization rate among AIDS patients. Therefore, this study aimed to determine causes and predictors of hospital admission as well as in-hospital mortality amongst human immunodeficiency virus (HIV)/AIDS-infected patients on HAART.
Material and methods:
This was a multi-center cross-sectional study, and included HIV/AIDS patients who were admitted to secondary and tertiary care hospitals in Oromia Regional State from May 1, 2017, to August 30, 2017. Data were collected from hospitalized HIV/AIDS patients using structured checklist and interview. Results were analyzed with Statistical Package for Social Sciences (SPSS) software, version 22. Bivariate and multivariable logistic regression analysis were performed to evaluate association, and p-value < 0.05 was used to determine relationship between dependent and independent variables.
Results:
Out of 171 participants enrolled, 105 (61%) were hospitalized due to opportunistic infections. Age ranged from 40 to 49 (AOR = 0.30; 95% CI: 0.09-0.98%) vs. 18-29, females (AOR = 2.41; 95% CI: 1.11-5.24%), CD4+ count less than 200 (AOR = 10.32; 95% CI: 3.49-30.52%), and poor adhered (AOR = 2.78; 95% CI: 1.21-6.41%) were significantly related to hospitalization with opportunistic infections (AIDS-related illnesses). Among admitted patients, 20 (11.7%) died in hospital. Poorly adherent patients and those who spent 9 days or more in hospital were more exposed to in-hospital death, with AOR = 3.093; 95% CI: 1.012-9.453% and AOR = 4.533; 95% CI: 1.371-14.985%, respectively.
Conclusions:
The major causes of hospitalization were HIV/AIDS-related illnesses. Adherence to the HIV drug regimen is warranted to minimize hospitalization with opportunistic infections and HIV/AIDS mortality.
Highly active antiretroviral therapies (HAART) decrease the incidence, morbidity, and mortality of acquired immunodeficiency syndrome (AIDS) dramatically. However, current research reported an increased hospitalization rate among AIDS patients. Therefore, this study aimed to determine causes and predictors of hospital admission as well as in-hospital mortality amongst human immunodeficiency virus (HIV)/AIDS-infected patients on HAART.
Material and methods:
This was a multi-center cross-sectional study, and included HIV/AIDS patients who were admitted to secondary and tertiary care hospitals in Oromia Regional State from May 1, 2017, to August 30, 2017. Data were collected from hospitalized HIV/AIDS patients using structured checklist and interview. Results were analyzed with Statistical Package for Social Sciences (SPSS) software, version 22. Bivariate and multivariable logistic regression analysis were performed to evaluate association, and p-value < 0.05 was used to determine relationship between dependent and independent variables.
Results:
Out of 171 participants enrolled, 105 (61%) were hospitalized due to opportunistic infections. Age ranged from 40 to 49 (AOR = 0.30; 95% CI: 0.09-0.98%) vs. 18-29, females (AOR = 2.41; 95% CI: 1.11-5.24%), CD4+ count less than 200 (AOR = 10.32; 95% CI: 3.49-30.52%), and poor adhered (AOR = 2.78; 95% CI: 1.21-6.41%) were significantly related to hospitalization with opportunistic infections (AIDS-related illnesses). Among admitted patients, 20 (11.7%) died in hospital. Poorly adherent patients and those who spent 9 days or more in hospital were more exposed to in-hospital death, with AOR = 3.093; 95% CI: 1.012-9.453% and AOR = 4.533; 95% CI: 1.371-14.985%, respectively.
Conclusions:
The major causes of hospitalization were HIV/AIDS-related illnesses. Adherence to the HIV drug regimen is warranted to minimize hospitalization with opportunistic infections and HIV/AIDS mortality.
REFERENCES (31)
1.
Global AidsUpdate UNAIDS | 2016. [Internet]. Available from: https://www.unaids.org/sites/d... (Accessed: 20.06.2017).
2.
Míguez MJ, Rosenberg R, Burbano X, Malow R. Cholesterol as a mediator of alcohol-induced risks for respiratory disease hospitalizations among people living with HIV. J AIDS Clin Res 2011; Suppl 1: 001.
4.
Characteristics of natural killer cells in Malaysian HIV patients presenting with immune restoration disease after ART. J AIDS Clinic Res 2010; 1: 102.
5.
Achhra AC, Zhou J, Dabis F, et al. Difference in absolute CD4+ count according to CD4 percentage between Asian and Caucasian HIV-infected patients. J AIDS Clin Res 2010; 1: 1-4.
6.
Stoneburner R, Korenromp E, Lazenby M, et al. Using health surveillance systems data to assess the impact of AIDS and antiretroviral treatment on adult morbidity and mortality in Botswana. PLoS One 2014; 9: e100431.
7.
Catumbela E, Freitas A, Lopes F, et al. HIV disease burden, cost, and length of stay in Portuguese hospitals from 2000 to 2010: a cross-sectional study. BMC Health Serv Res 2015; 15: 144.
8.
Báez-Saldaña R, Villafuerte-García A, Cruz-Hervert P, et al. Asso ciation between highly active antiretroviral therapy and type of infectious respiratory disease and all-cause in-hospital mortality in patients with HIV/AIDS: a case series. PLoS One 2015; 10: e0138115.
9.
Bachhuber MA, Southern WN. Hospitalization rates of people living with HIV in the United States, 2009. Public Health Rep 2014; 129: 178-186.
10.
Falster K, Wand H, Donovan B, et al. Hospitalizations in a cohort of HIV patients in Australia, 1999–2007. AIDS 2010; 24: 1329.
11.
Hajiabdolbaghi M, Jafari S, Mansouri S, Yaghoobi MH. Hospitalizations and its related factors in HIV/AIDS patients in Tehran, Iran. Med J Islam Repub Iran 2014; 28: 70.
12.
Coelho LE, Ribeiro SR, Veloso VG, Grinsztejn B, Luz PM. Hospitalization rates, length of stay and in-hospital mortality in a cohort of HIV infected patients from Rio de Janeiro, Brazil. Braz J Infect Dis 2017; 21: 190-195.
13.
Namutebi A, Kamya M, Byakika-Kibwika P. Causes and outcome of hospitalization among HIV-infected adults receiving antiretroviral therapy in Mulago hospital, Uganda. Afr Health Sci 2013; 13: 977-985.
14.
Liwlompaisan W, Kiertiburanakul S. Causes of hospitalizations among HIV-infected adults in the highly active antiretroviral therapy era in Thailand. J Infect Dis Antimicrob Agents 2013; 30: 5-14.
15.
Kumar A, Kilaru KR, Sandiford S, Forde S. Trends in the HIV related hospital admissions in the HAART era in Barbados, 2004-2006. AIDS Res Ther 2007; 4: 4.
16.
Lartey M, Asante-Quashie A, Essel A, Kenu E, Ganu V, Neequaye A. Causes of death in hospitalized HIV patients in the early anti-retroviral therapy era. Ghana Med J 2015; 49: 7-11.
17.
Guerro AC, Andretta IB, Bello SL, Trevisol DJ, Schuelter-Trevisol F. Causes of hospital admission of AIDS patients in southern Brazil, 2007 to 2012. Rev Soc Bras Med Trop 2014; 47: 632-636.
18.
Bane A, Yohannes A, Fekade D. Morbidity and mortality of adult patients with HIV/AIDS at Tikur Anbessa Teaching Hospital, Addis Ababa, Ethiopia. Ethiop Med J 2003; 41: 131-140.
19.
Dávalos DM, Hlaing WM, Kim S. Recent trends in hospital utilization and mortality for HIV infection: 2000-2005. J Natl Med Assoc 2010; 102: 1131-1138.
20.
Sobhani R, Basavaraj A, Gupta A, et al. Mortality and clinical characteristics of hospitalized adult patients with HIV in Pune, India. Indian J Med Res 2007; 126: 116-121.
21.
Sharifi-Mood B, Alavi-Naini R, Salehi M, Hashemi M, Rakhshani F. Spectrum of clinical disease in a series of hospitalized HIV-infected patients from southeast of Iran. Saudi Med J 2006; 27: 1362.
22.
Abgrall JM. Healing or Stealing? Medical Charlatans in the New Age. Algora Publishing, 2007.
23.
Pabst H, Crawford J. L-tetramisole. Enhancement of human lymphocyte response to antigen. Clin Exp Immunol 1975; 21: 468.
24.
Charurat M, Oyegunle M, Benjamin R, et al. Patient retention and adherence to antiretrovirals in a large antiretroviral therapy program in Nigeria: a longitudinal analysis for risk factors. PLoS One 2010; 5: e10584.
26.
Schneiderman N. A measurement model of medication adherence to highly active antiretroviral therapy and its relation to viral load in HIV-positive adults. AIDS Patient Care STDS 2006; 20: 701-711.
27.
Eckman MH, Wise R, Leonard AC, et al. Impact of health literacy on outcomes and effectiveness of an educational intervention in patients with chronic diseases. Patient Educ Couns 2012; 87: 143-151.
28.
Biadgilign S, Deribew A, Amberbir A, Deribe K. Barriers and facilitators to antiretroviral medication adherence among HIV-infected paediatric patients in Ethiopia: A qualitative study. SAHARA.
30.
Lewden C, Drabo YJ, Zannou DM, et al. Disease patterns and causes of death of hospitalized HIV‐positive adults in West Africa: a multi country survey in the antiretroviral treatment era. J Int AIDS Soc 2014; 17: 18797.
31.
Fonsah JY, Njamnshi AK, Kouanfack C, et al. Adherence to anti retroviral therapy (ART) in Yaoundé-Cameroon: association with opportunistic infections, depression, ART regimen and side effects. PLoS One 2017; 12: e0170893.
Share
RELATED ARTICLE
| eISSN: | 1732-2707 |
| ISSN: | 1730-1270 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
